Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma. [PDF]
Xu M +16 more
europepmc +1 more source
Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges. [PDF]
Habib R +4 more
europepmc +1 more source
Adjuvant Larotrectinib in a Resected Secretory Carcinoma-Like Lung Adenocarcinoma Harboring EML4-NTRK3 Fusion: Case Report. [PDF]
Cordeiro de Lima VC +8 more
europepmc +1 more source
Traumatic life experiences during critical periods lead to diverse developmental trajectories. [PDF]
Morelli G +16 more
europepmc +1 more source
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states. [PDF]
Calvo Fernández E +25 more
europepmc +1 more source
Three novel concomitant NTRK2 fusions in medullary thyroid carcinoma with diagnostic implications. [PDF]
Chu J, Zhao N, Yu Q, Qin L, Zhang D.
europepmc +1 more source
Targeting ANXA1/TRKA axis enhances immunotherapy sensitivity in neural invasion-positive gastric cancer. [PDF]
Jiang T +10 more
europepmc +1 more source
Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. [PDF]
Shen Y +11 more
europepmc +1 more source
Paediatric and Adult Solid Tumours Exhibiting NTRK Gene Fusions in Australia, 2020-2044: A Population-Based Statistical Modelling Study. [PDF]
Luo Q +5 more
europepmc +1 more source
RingKin: portraying the vast macrocyclic chemical universe surrounding kinase drugs. [PDF]
Diao Y +14 more
europepmc +1 more source

